Logo
x

Search

Subscribe Now

Biostar Pharma

Biostar Pharma Reports the US FDA’s IND Clearance for P-II Trial of Utidelone to Treat Breast Cancer Brain Metastasis

Biostar Pharma Reports the US FDA’s IND Clearance for P-II Trial of Utidelone to Treat Breast Cancer Brain Metastasis

  • July 5, 2024
Biostar Pharma’s Utidelone Injectable Receives the USFDA’s Orphan Drug Designation for Treating Breast Cancer Brain Metastasis

Biostar Pharma’s Utidelone Injectable Receives the USFDA’s Orphan Drug Designation for Treating Breast Cancer Brain Metastasis

  • April 1, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.